Back to Search
Start Over
A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus intravenous low-dose nivolumab (NIVO) in patients with advanced solid tumors
- Source :
- Vrije Universiteit Brussel
- Subjects :
- 0301 basic medicine
Oncology
medicine.medical_specialty
Myeloid
business.industry
Cyclophosphamide/Doxorubicin/Etoposide
Low dose
Phases of clinical research
Ipilimumab
Hematology
Avelumab
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
medicine.anatomical_structure
030220 oncology & carcinogenesis
Internal medicine
medicine
In patient
Nivolumab
business
medicine.drug
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Vrije Universiteit Brussel
- Accession number :
- edsair.doi.dedup.....0b97ade504725395a8f8a971072d9231